sub:assertion {
  <http://purl.obolibrary.org/obo/DOID_13146> bl:category bl:Disease .
  sub:association rdf:object <http://purl.obolibrary.org/obo/DOID_13146> ;
    rdf:predicate bl:treats ;
    rdf:subject <https://identifiers.org/drugbank:DB00362> ;
    a rdf:Statement ;
    rdfs:label "eraxis is indicated for use in adults for the treatment of the following fungal infections listed below specimens for fungal culture and other relevant laboratory studies including histopathology should be obtained prior to therapy to isolate and identify causative organism s therapy may be instituted before the results of the cultures and other laboratory studies known however once these results become available antifungal therapy should be adjusted accordingly anidulafungin is an echinocandin antifungal indicated in adults for the treatment of candidemia and other forms of candida 1 1 esophageal candidiasis 1 2 limitations of use has not been studied in endocarditis osteomyelitis and meningitis due to candida 1 3 eraxis is indicated for the treatment of candidemia and the following candida see clinical studies 14 1 clinical pharmacology microbiology 12 4 eraxis is indicated for the treatment of esophageal candidiasis see clinical studies 14 2 table 1 eraxis has not been studied in endocarditis osteomyelitis and meningitis due to candida" ;
    bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
    bl:provided_by <https://w3id.org/um/NeuroDKG> ;
    bl:relation schema:TreatmentIndication .
  <https://identifiers.org/drugbank:DB00362> bl:category bl:Drug .
}